• SHC-1 Inhibition Enhances CFTR Surface Abundance in Epitheli

  2026-06-16

  The reference study elucidates how inhibition of the adaptor protein SHC-1 modulates the plasma membrane abundance of the CFTR chloride channel across different epithelial cell models. Its findings clarify conserved and cell-type-specific pathways regulating CFTR trafficking, refining strategies for both cystic fibrosis research and the modeling of secretory disorders.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-06-16

  Wang et al. reveal a novel METTL16-SENP3-LTF signaling pathway that confers ferroptosis resistance and supports tumorigenesis in hepatocellular carcinoma (HCC). Their findings clarify how m6A RNA modification and iron regulation intersect in HCC pathogenesis, highlighting new targets for sensitizing tumors to ferroptosis-based therapies.

• Amikacin Sulfate: Intracellular Pharmacology and Precision D

  2026-06-15

  Explore the advanced intracellular pharmacology of Amikacin Sulfate and its role in targeted drug delivery for non-tuberculous mycobacterial infections. This in-depth guide uniquely dissects intracellular uptake, in vivo precision, and practical assay design to empower translational research.

• Dissecting In Vitro Drug Responses: Insights from Schwartz 2

  2026-06-15

  Schwartz (2022) presents a rigorous framework for distinguishing between proliferative arrest and cell death in in vitro cancer drug assays, clarifying that these common metrics reflect distinct drug effects. This methodological advance has direct implications for the evaluation and optimization of topoisomerase 1 inhibitors and other antitumor agents.

• Topotecan HCl in Mechanism-Based Oncology: Beyond Viability

  2026-06-14

  Explore Topotecan HCl as a topoisomerase 1 inhibitor through the lens of advanced drug response evaluation—delving into mechanistic insights and practical assay strategies that go beyond conventional viability endpoints.

• Ceruletide in Pancreatic Function Research: Protocols & Inno

  2026-06-13

  Ceruletide (Caerulein) is a gold-standard tool for modeling pancreatic fibrosis and digestive physiology, enabling reproducible workflows that bridge foundational research with cutting-edge regenerative approaches. This article distills advanced experimental protocols, troubleshooting strategies, and the translational impact of recent mechanistic discoveries on pancreatic fibrosis models.

• Capsaicin-Induced Autophagy Preserves BMSC Function via PI3K

  2026-06-12

  This study demonstrates that capsaicin activates autophagy in bone marrow stromal cells (BMSCs) under oxidative stress, protecting their survival and osteogenic differentiation through TRPV1-mediated calcium influx and PI3K/AKT/mTOR pathway inhibition. The findings highlight a novel mechanism for improving BMSC resilience in osteoporosis and suggest potential research avenues for modulating PI3K signaling in cellular models.

• Pioglitazone in Advanced Immunometabolic Research: Beyond Di

  2026-06-12

  Explore how Pioglitazone, a selective PPARγ agonist, drives innovation in immunometabolic disease modeling—including unique insights into macrophage polarization and STAT pathway modulation. This deep-dive reveals applications and protocol strategies not found in existing content.

• Proteinase K: Broad-Spectrum Serine Protease for DNA Integri

  2026-06-11

  Proteinase K is a broad-spectrum serine protease crucial for protein hydrolysis and enzyme contaminant removal in molecular biology. APExBIO’s recombinant Proteinase K (K1037) enables efficient genomic DNA isolation while preserving DNA integrity. Its robust inhibitor resistance and operational flexibility make it a gold-standard for DNA preparation workflows.

• Saquinavir in Advanced HIV and Lung Permeability Research

  2026-06-11

  Explore the pivotal role of Saquinavir as an HIV protease inhibitor in antiretroviral and permeability research. This article uniquely examines its integration with state-of-the-art biomimetic chromatography and mass spectrometry for preclinical assay optimization.

• Cy3 TSA Fluorescence System Kit: Amplifying Sensitivity in I

  2026-06-10

  The Cy3 TSA Fluorescence System Kit revolutionizes immunohistochemistry and in situ hybridization by enabling detection of low-abundance targets with unparalleled fluorescence amplification. This workflow-driven guide explores how APExBIO’s kit empowers researchers to achieve robust, high-sensitivity imaging while providing actionable protocol refinements and troubleshooting strategies.

• miR-3180 Regulates Lipid Metabolism to Suppress HCC Progress

  2026-06-10

  Hong et al. (2023) identified miR-3180 as a dual suppressor of lipid synthesis and uptake in hepatocellular carcinoma (HCC), inhibiting tumor growth and metastasis by targeting SCD1 and CD36. This study highlights miR-3180’s potential as a therapeutic target and prognostic biomarker, advancing metabolic research in liver cancer.

• PRINT Enables Precise RNA-Guided Transgene Insertion in Huma

  2026-06-09

  The reference study introduces PRINT, an RNA-mediated approach for site-specific transgene insertion into human safe-harbor loci, utilizing eukaryotic retroelement proteins. This innovation achieves high-efficiency, full-length gene integration without donor DNA, reducing mutagenesis and immune risks—an advance with substantial implications for gene therapy research.

• EZ Cap™ EPO mRNA (ψUTP): Next-Gen Stability for Erythropoies

  2026-06-09

  Explore how EZ Cap™ EPO mRNA empowers robust erythropoiesis and neurorepair research by combining advanced mRNA capping, pseudouridine modification, and superior stability. Learn how this APExBIO innovation uniquely addresses assay reproducibility and translational hurdles.

• Lactobacillus gasseri Modulates Colitis via NR1I3–E-cadherin

  2026-06-08

  The referenced study demonstrates that Lactobacillus gasseri ATCC33323 significantly ameliorates DSS-induced colitis in mice through the NR1I3-mediated regulation of E-cadherin. This mechanistic insight advances our understanding of probiotic interventions in intestinal barrier function and offers a refined target for future IBD therapies.

16396 records 1/1094 page Next 12345 下5页 Last page